Lev Facher, STAT

Lev Facher

STAT

Washington, DC, United States

Contact Lev

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Start free trial

Recent:
  • STAT
Past:
  • Scientific American
  • Business Insider
  • SF Chronicle

Recent articles by Lev:

Resistance to FDA's opioid-disposal plan raises concerns about CADCA, a powerful advocacy group

CADCA’s relationship with Deterra — and its opposition to a opioid-disposal proposal that would cut into Deterra’s bottom line — is a case study in the murky world of Washington advocacy. → Read More

Top U.S. addiction researcher calls for broad deregulation of methadone

“Methadone is underutilized in part because it requires such stringent conditions in order to be prescribed. We have a pretty powerful health structure in the United States, and we should optimize it to maximize access." → Read More

Fentanyl isn’t just causing overdoses. It’s making it harder to start addiction treatment

Even as fentanyl sends overdose deaths soaring, it threatens to make the world’s most-prescribed addiction drug inaccessible to the increasing number of patients who need it. → Read More

Providers of methadone treatment say a big increase in access could backfire

With overdose deaths appallingly high, advocates say it should be much easier to prescribe methadone. Some providers worry it could do more harm than good. → Read More

When it comes to addiction, Americans’ word choices are part of the problem

“Words matter tremendously, and much of the language we use when we talk about addiction is very dissimilar from the language we use for other health conditions." → Read More

Documents detail how pharmacy giants Walgreens, CVS, and Walmart failed patients in the opioid epidemic

Retail pharmacies shared more of the blame for the opioid crisis than previously reported — through willful blindness, weak controls, resistance from executives to improve monitoring, and in some cases, ineptitude. → Read More

The meth crisis is worse than ever, but new treatments might be around the corner

Meth addiction has no pharmacological treatment options. Could monoclonal antibodies be an answer? → Read More

Fentanyl test strips could help save lives. In many states, they’re still illegal

The practice of “drug-checking” — essentially, testing illicit drugs to see if they contain unknown toxins — has remained controversial even as the crisis of fentanyl deaths has attracted national attention. → Read More

Biden administration has simple way to cut overdose deaths, experts say: expand methadone access

Methadone is a lifesaving treatment for people addicted to opioids. But a vast web of rules and regulations make it extremely difficult to access. → Read More

White House to launch effort to develop next generation of Covid vaccines

Exclusive: The Biden administration is preparing a sweeping initiative to develop a next generation of Covid-19 immunizations that would thwart future coronavirus variants and dramatically reduce rates of coronavirus infection or transmission. → Read More

After STAT report, GOP lawmakers seek answers about defunct NIH oversight committee

An NIH oversight committee mysteriously stopped meeting seven years ago. Republican lawmakers want to know why. → Read More

Key Senate committee proposes a council to ensure FDA better coordinates on accelerated approvals

Key senators want to create a council meant to help the FDA sidestep some of the issues that plagued its approval of the Alzheimer’s drug Aduhelm. → Read More

Dr. Oz peddles medical misinformation — but could his political rise have a silver lining for public health?

Dr. Oz has made a career of peddling misinformation — but he’s also given sound advice on vaccines and masks. Could his political rise have a silver lining for science? → Read More

‘Lives could be at stake’: CDC’s Walensky warns of dire stakes surrounding abortion access

CDC Director Rochelle Walensky commented on the implications of overturning Roe v. Wade, downplayed mixed messaging on Covid policy, and spoke about the future of the CDC. → Read More

A new nonprofit wants to rewrite the playbook for how the U.S. government funds science

“Playing it safe doesn’t get you the best science. Some of the greatest scientific discoveries came from people who were taking chances," said Stuart Buck, executive director of the Good Science Project, a new nonprofit. → Read More

Biden’s new high-stakes research agency needs a home. For cities and states, the race for ARPA-H is on

The race is on to become the new home of ARPA-H — and no state is more excited than Texas. → Read More

Biden’s high-stakes biomedical science agency ARPA-H will be part of the NIH — but there’s a twist

The Biden administration’s new research agency ARPA-H will exist as part of the NIH — but with a twist. → Read More

The new White House Covid coordinator is great on TV. Is that what America’s pandemic response needs now?

Ashish Jha, the new White House Covid response coordinator, is great on TV. Is that what America’s pandemic response needs now? → Read More

Biden’s agency to 'end cancer as we know it' is finally real. But it has a chaotic road ahead

Congress funded ARPA-H, the agency that President Biden has pledged will help “end cancer as we know it.” But lawmakers left most of the major questions about the new agency unresolved. → Read More

Nurses, more powerful and visible after Covid, capitalize on new clout in Washington

Empowered by their role fighting Covid, nurses are planning a march on Washington, and pushing lawmakers and Biden to improve their pay and enact new workplace protections. → Read More